Overview of medication management in palliative care

Kuruvilla, 2018

Medication use in palliative care is principally aimed at managing symptoms, relieving distress and improving quality of life. Medication management in palliative care involves ensuring medications are taken properly and achieving the desired therapeutic outcome in line with the goals of care of the patient. Factors that influence medication management are listed in Factors that influence medication management for patients with palliative care needs.

Table 1. Factors that influence medication management for patients with palliative care needs

Key factors

Examples

patient factors

level of health literacy

understanding of, attitudes to, and preferences about medication, including cultural attitudes

stage of disease and prognosis

comorbidities

medication adherence

ability to swallow

ability to administer medications (eg inhalers, eye drops)

dexterity

carer support

place of care

community, residential facility (disability or aged care), prison, hospital, palliative care unit (hospice)

metropolitan, rural, remote

intent of medication

disease modification

symptom management (acute or chronic)

preventive health care and general wellbeing (eg supplements, complementary medicines)

medication safety

adverse drug reactions

quantity of medication supplied

medication storage and disposal

nonmedical use of medication by patients or carers [NB1]

complexity of medication regimen

use of a drug to treat multiple comorbidities

involvement of multiple prescribers

frequent changes to medications and doses

drugs associated with a high risk of causing harm to patients

combination of regular and as-required drug therapy

complementary, alternative and over-the-counter therapies that patients commonly access without prescriber involvement

medication access

availability in different settings

quantity and frequency of medication supply (eg for subcutaneous doses via continuous subcutaneous infusions [CSCI])

cost

registered use or indication

legislative restrictions (eg for opioids)

Note: NB1: Nonmedical use describes the use of medications that does not align with the directed use; for example, use in order to become intoxicated or to treat a symptom other than the clinician intendedAustralian Institute of Health and Welfare (AIHW)McNeely, 2014.

Safe and effective use of medications in patients with palliative care needs can be enhanced through: